N@N

Geoffrey Porges Maintained (ABBV) at Buy with Decreased Target to $107 on, Oct 30th, 2017

Geoffrey Porges of Leerink Swann, Maintained "AbbVie Inc." (ABBV) at Buy with Decreased Target from $108 to $107 on, Oct 30th, 2017.

Geoffrey has made no other calls on ABBV in the last 4 months.

There are 6 other peers that have a rating on ABBV. Out of the 6 peers that are also analyzing ABBV, 3 agree with Geoffrey's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Geoff Meacham of "Barclays" Maintained at Hold with Increased Target to $90 on, Friday, October 13th, 2017
• Marc Goodman of "UBS" Maintained at Hold with Increased Target to $95 on, Friday, October 13th, 2017
• Gregg Gilbert of "Deutsche Bank" Maintained at Hold with Increased Target to $66 on, Monday, July 17th, 2017

These are the ratings of the 3 analyists that currently disagree with Geoffrey

---

• Steve Scala of "Cowen & Co." Upgraded from Hold to Buy on, Wednesday, October 11th, 2017
• Jeffrey Holford of "Jefferies" Maintained at Strong Buy with Increased Target to $107 on, Friday, September 15th, 2017
• Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $95 on, Thursday, August 17th, 2017

Contributing Sources

---